| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network
|
Sun, Min
|
|
2019
|
175 |
1 |
p. 59-75
|
article
|
| 2 |
Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?
|
Coopey, Suzanne B.
|
|
2019
|
175 |
1 |
p. 1-4
|
article
|
| 3 |
Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction
|
Hussain, Yasin
|
|
2019
|
175 |
1 |
p. 239-246
|
article
|
| 4 |
Change in study randomization allocation needs to be included in statistical analysis: comment on ‘Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study’
|
Dickinson, Stephanie L.
|
|
2019
|
175 |
1 |
p. 263-264
|
article
|
| 5 |
Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers
|
Savva, Constantinos
|
|
2019
|
175 |
1 |
p. 105-115
|
article
|
| 6 |
Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
|
Nitz, Ulrike
|
|
2019
|
175 |
1 |
p. 265-266
|
article
|
| 7 |
Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk
|
Weiss, Anna
|
|
2019
|
175 |
1 |
p. 229-237
|
article
|
| 8 |
Differences between screen-detected and interval breast cancers among BRCA mutation carriers
|
Pilewskie, Melissa
|
|
2019
|
175 |
1 |
p. 141-148
|
article
|
| 9 |
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)—PathIES
|
Szijgyarto, Zsolt
|
|
2019
|
175 |
1 |
p. 149-163
|
article
|
| 10 |
Efficacy of self-administered complex decongestive therapy on breast cancer-related lymphedema: a single-blind randomized controlled trial
|
Ligabue, M. B.
|
|
2019
|
175 |
1 |
p. 191-201
|
article
|
| 11 |
Factors influencing the use of extended adjuvant endocrine therapy
|
Kadakia, Kunal C.
|
|
2019
|
175 |
1 |
p. 181-189
|
article
|
| 12 |
HER2 positive breast cancer patients having HER2 loss after neoadjuvant chemotherapy should still be treated with adjuvant anti-HER2 treatment
|
Altundag, Kadri
|
|
2019
|
175 |
1 |
p. 261
|
article
|
| 13 |
High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer
|
Bick, Ulrich
|
|
2019
|
175 |
1 |
p. 217-228
|
article
|
| 14 |
ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness
|
Liu, Yin
|
|
2019
|
175 |
1 |
p. 77-90
|
article
|
| 15 |
Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women
|
O’Meara, Tess
|
|
2019
|
175 |
1 |
p. 247-259
|
article
|
| 16 |
Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases
|
Liu, Zhi-Hua
|
|
2019
|
175 |
1 |
p. 51-57
|
article
|
| 17 |
Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery
|
DiNome, Maggie L.
|
|
2019
|
175 |
1 |
p. 165-170
|
article
|
| 18 |
Prognostic effects of abnormal DNA damage response protein expression in breast cancer
|
Suh, Koung Jin
|
|
2019
|
175 |
1 |
p. 117-127
|
article
|
| 19 |
Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer
|
Camp, Nicola J.
|
|
2019
|
175 |
1 |
p. 129-139
|
article
|
| 20 |
Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort
|
Jung, Jiwoong
|
|
2019
|
175 |
1 |
p. 203-215
|
article
|
| 21 |
Revealing clonality and subclonality of driver genes for clinical survival benefits in breast cancer
|
Lan, Yujia
|
|
2019
|
175 |
1 |
p. 91-104
|
article
|
| 22 |
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells
|
Strekalova, Elena
|
|
2019
|
175 |
1 |
p. 39-50
|
article
|
| 23 |
Tamoxifen and pregnancy: an absolute contraindication?
|
Schuurman, T. N.
|
|
2019
|
175 |
1 |
p. 17-25
|
article
|
| 24 |
The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea
|
Rugo, Hope S.
|
|
2019
|
175 |
1 |
p. 5-15
|
article
|
| 25 |
The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer
|
El-Ansari, Rokaya
|
|
2019
|
175 |
1 |
p. 27-38
|
article
|
| 26 |
The effects of psychosexual counseling on sexual quality of life and function in Iranian breast cancer survivors: a randomized controlled trial
|
Fatehi, Shakiba
|
|
2019
|
175 |
1 |
p. 171-179
|
article
|
Journal description